Stem Cell Banking For Dogs Means Fighting Illness in the Future
An animal biotech company is leading the path for new ways to care for our pets, as it has launched the first and only nationwide stem cell banking opportunity for dogs.
Gallant, an animal biotech company that just acquired the veterinary division of Cook-Regentec, has announced that they now offer the nation’s first and only stem cell banking solution for dogs. The patent-pending technology will revolutionize the way disease and illness in dogs is handled, in similar fashion to how it’s revolutionized medical care for humans.
While human stem-cell banking often comes when babies are born, and comes from their cord blood and tissues, it is also available in limited opportunity for humans. But Gallant, knowing that furry family members can benefit from the life-changing stem cell technology that is rapidly evolving, has now made banking our dog’s stem cells a possibility too.
The process begins with stem cells that are collected from tissues a veterinarian obtains during a routine neuter or spay procedure. Typically those young stem cells would be otherwise disposed of, but with Gallant’s stem cell collection, they can be cryopreserved and used to treat future illnesses your dog may have. It’s the first and only non-invasive animal stem cell collection process that is available and promises to revolutionize veterinary medicine.
Typical stem-cell banking procedures for animals are invasive and costly, and often happen when animals are already older and/or ill. Taking the stem cells from younger, healthy dogs during a routine process now gives vets and pet parents more options than they’ve ever had before.
The launch came after extensive research and experience on the part of Gallant’s scientists and researchers, as well as the veterinarians from the acquired division of Cook-Regentec. Hundreds of cats and dogs have been treated with their own banked stem cells and clinical studies continue to show the benefits of stem cell therapies for illness such as osteoarthritis, chronic dry eye, atopic dermatitis and more. Because stem-cell therapy comes from the dog’s own body, it’s natural and can address issues at root causes.
The kit new puppy parents in the United States can order is shipped to their vet’s office before the spay/neuter process. The procedure fee is $395, and Gallant offers storage plans that range from $95/year to $595 for a lifetime. And, to celebrate the launch, for a limited time, Gallant will waive the $395 procedure fee!
Gallant was founded by the founder and CEO of Dog Vacay, Aaron Hirschhorn. Hirschhorn merged DogVacy with Rover, and additionally, Richard Jennings, Darryl Rawlings, Art Antin and Dr. David Howarth line the board. Richard Jennings is the CEO of California Cryobank, a cord blood banking company. Darryl Rawlings is the founder and CEO of Trupanion, a pet insurance company. Art Antin is the founder of VCA and Dr. David Howarth is the former president of PetSmart Charities in Canada and the United States.
It’s a clearly impressive board, and all are committed to treating and healing pets. Hirschhorn himself suffered from debilitating chronic back issues and watched his dog Rocky suffer from debilitating arthritis. It was his desire to help her and all pets in pain to heal through the power of regenerative medicine.
Regenerative medicine is often more cost-effective than traditional and conventional treatment options like surgery. Surgeries often cost thousands of dollars and may or may not work. Now, with the power of stem cell therapy, Gallant looks to offer pet parents the power of regenerative medicine at an affordable cost. And that is a win for pets and their parents alike!